Pfizer Explores Sale of Consumer Healthcare Business
Pfizer Inc. reported last month that it will be exploring strategic alternatives for Pfizer Consumer Healthcare (PCH), including retaining, spinning off or selling the business. PCH's well-balanced product portfolio, anchored by key brands Listerine, Benadryl and Visine, contributes to more than $100 million in annual sales.